These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4716976)

  • 1. [Antineoplastic effect of N,N',N''-trihydroxymethylmelamine and analogous compounds. 23. Cytostatic agents].
    Schönenberger H; Schmidt F; Bindl L
    Arch Pharm (Weinheim); 1973 Apr; 306(4):274-84. PubMed ID: 4716976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumour inhibitory N-(bis--(2-chlorethyl)-aminomethyl)-urethanes (author's transl)].
    Schïnenberger H; Schmidt F; Bindl L
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Nov; 84(3):277-40. PubMed ID: 128219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and tumor inhibiting effect of N-(bis(2-chlorethyl)-aminomethyl)-amides. 21. Cytostatic agents].
    Schönenberger H; Bindl L; Adam A
    Arch Pharm (Weinheim); 1973 Jan; 306(1):64-75. PubMed ID: 4691046
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ineffectiveness of CH 23 in Yoshida sarcoma of the rat and mouse sarcoma 180].
    Schmähl D; Ballweg H; Berndt F; Osswald H
    Arzneimittelforschung; 1968 May; 18(5):588-9. PubMed ID: 5755887
    [No Abstract]   [Full Text] [Related]  

  • 6. The antitumoral properties of 1-benzyl-3-acetyl-pyridinium chloride.
    Milder R; Jamra M; Cilento G
    Arzneimittelforschung; 1966 Jan; 16(1):44-5. PubMed ID: 6013756
    [No Abstract]   [Full Text] [Related]  

  • 7. The sensitivity of a Yoshida sarcoma to methylene dimethane sulphonate.
    Fox BW
    Int J Cancer; 1969 Jan; 4(1):54-60. PubMed ID: 5346476
    [No Abstract]   [Full Text] [Related]  

  • 8. Identical karyotypes in acquired drug-resistant sublines of Yoshida sarcoma.
    Ujhåzy V
    Neoplasma; 1974; 21(6):665-9. PubMed ID: 4444746
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of meso- and racemic-N,N'-dibutyl- , '-di-(3-chloro-4-methoxyphenyl)-ethylenediamine on 7,12-dimethylbenz-( )-anthracene induced mammary tumor of the Sprague-Dawley rat. 14. Cytostatic agents].
    Schönenberger H; Griebl G; Adam D; Adam A
    Arzneimittelforschung; 1971 Dec; 21(12):2104-6. PubMed ID: 5171985
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the carrying molecule in the cross-resistance against sugar alcohol derivatives.
    Gáti E; Horváth IP
    Eur J Cancer (1965); 1969 Dec; 5(6):553-7. PubMed ID: 5386716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the antimicrobial and tumor-inhibiting properties of N-analogous stilbestrols. 15. Cytostatica].
    Schönenberger H; Bastug T
    Arch Pharm (Weinheim); 1972 Apr; 305(4):285-90. PubMed ID: 5047663
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of macromolecules upon the rates of hydrolysis of aromatic nitrogen mustard derivatives.
    Hopwood WJ; Stock JA
    Chem Biol Interact; 1971 Dec; 4(1):31-9. PubMed ID: 5156335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems in combined radio-cytostatic therapy. 7. Syncarcinolytic studies using 5-fluorouracil, natulan and proresid in Crocker sarcoma 180 of mice].
    Ringleb D; Krieg R; Sauer D
    Strahlentherapie; 1969 Oct; 138(4):423-8. PubMed ID: 5352491
    [No Abstract]   [Full Text] [Related]  

  • 14. [An experimental study of the anti-tumor activity of several alkylating compounds].
    Ivanova LA; Degutis IuA
    Vopr Onkol; 1969; 15(5):92-4. PubMed ID: 5360153
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH.
    CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T
    Neoplasma; 1964; 11():137-44. PubMed ID: 14160693
    [No Abstract]   [Full Text] [Related]  

  • 17. 2- and 6-methyl-1,4-naphthoquinone derivatives and potential bioreductive alkylating agents.
    Antonini I; Lin TS; Cosby LA; Dai YR; Sartorelli AC
    J Med Chem; 1982 Jun; 25(6):730-5. PubMed ID: 7097727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of compounds on a spectrum of rat tumors.
    Sugiura K; Schmid FA; Schmid MM; Brown GF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):231-308. PubMed ID: 4350013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.